566 related articles for article (PubMed ID: 24470103)
21. FGF23, klotho and vitamin D interactions: What have we learned from in vivo mouse genetics studies?
Razzaque MS
Adv Exp Med Biol; 2012; 728():84-91. PubMed ID: 22396163
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets/osteomalacia.
Aono Y; Yamazaki Y; Yasutake J; Kawata T; Hasegawa H; Urakawa I; Fujita T; Wada M; Yamashita T; Fukumoto S; Shimada T
J Bone Miner Res; 2009 Nov; 24(11):1879-88. PubMed ID: 19419316
[TBL] [Abstract][Full Text] [Related]
23. Circulating levels of soluble alpha-Klotho are markedly elevated in human umbilical cord blood.
Ohata Y; Arahori H; Namba N; Kitaoka T; Hirai H; Wada K; Nakayama M; Michigami T; Imura A; Nabeshima Y; Yamazaki Y; Ozono K
J Clin Endocrinol Metab; 2011 Jun; 96(6):E943-7. PubMed ID: 21411554
[TBL] [Abstract][Full Text] [Related]
24. Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations.
Yu X; Sabbagh Y; Davis SI; Demay MB; White KE
Bone; 2005 Jun; 36(6):971-7. PubMed ID: 15869926
[TBL] [Abstract][Full Text] [Related]
25. FGF23 beyond Phosphotropic Hormone.
Takashi Y; Fukumoto S
Trends Endocrinol Metab; 2018 Nov; 29(11):755-767. PubMed ID: 30217676
[TBL] [Abstract][Full Text] [Related]
26. Modified-release oral calcifediol corrects vitamin D insufficiency with minimal CYP24A1 upregulation.
Petkovich M; Melnick J; White J; Tabash S; Strugnell S; Bishop CW
J Steroid Biochem Mol Biol; 2015 Apr; 148():283-9. PubMed ID: 25446887
[TBL] [Abstract][Full Text] [Related]
27. Osteocyte-specific deletion of Fgfr1 suppresses FGF23.
Xiao Z; Huang J; Cao L; Liang Y; Han X; Quarles LD
PLoS One; 2014; 9(8):e104154. PubMed ID: 25089825
[TBL] [Abstract][Full Text] [Related]
28. Klotho gene, phosphocalcic metabolism, and survival in dialysis.
Torres PU; Prié D; Beck L; De Brauwere D; Leroy C; Friedlander G
J Ren Nutr; 2009 Jan; 19(1):50-6. PubMed ID: 19121771
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of the DMP1 C-terminal fragment stimulates FGF23 and exacerbates the hypophosphatemic rickets phenotype in Hyp mice.
Martin A; David V; Li H; Dai B; Feng JQ; Quarles LD
Mol Endocrinol; 2012 Nov; 26(11):1883-95. PubMed ID: 22930691
[TBL] [Abstract][Full Text] [Related]
30. Genomic mechanisms controlling renal vitamin D metabolism.
Meyer MB; Pike JW
J Steroid Biochem Mol Biol; 2023 Apr; 228():106252. PubMed ID: 36657729
[TBL] [Abstract][Full Text] [Related]
31. Vitamin D and the regulation of placental inflammation.
Liu NQ; Kaplan AT; Lagishetty V; Ouyang YB; Ouyang Y; Simmons CF; Equils O; Hewison M
J Immunol; 2011 May; 186(10):5968-74. PubMed ID: 21482732
[TBL] [Abstract][Full Text] [Related]
32. Klotho Lacks an FGF23-Independent Role in Mineral Homeostasis.
Andrukhova O; Bayer J; Schüler C; Zeitz U; Murali SK; Ada S; Alvarez-Pez JM; Smorodchenko A; Erben RG
J Bone Miner Res; 2017 Oct; 32(10):2049-2061. PubMed ID: 28600880
[TBL] [Abstract][Full Text] [Related]
33. FGF23 Is Not Required to Regulate Fetal Phosphorus Metabolism but Exerts Effects Within 12 Hours After Birth.
Ma Y; Kirby BJ; Fairbridge NA; Karaplis AC; Lanske B; Kovacs CS
Endocrinology; 2017 Feb; 158(2):252-263. PubMed ID: 27929669
[TBL] [Abstract][Full Text] [Related]
34. Bone-kidney axis in systemic phosphate turnover.
Razzaque MS
Arch Biochem Biophys; 2014 Nov; 561():154-8. PubMed ID: 24997362
[TBL] [Abstract][Full Text] [Related]
35. A PAI-1 antagonist ameliorates hypophosphatemia in the Hyp vitamin D-resistant rickets model mouse.
Qian C; Ito N; Tsuji K; Sato S; Kikuchi K; Yoshii T; Miyata T; Asou Y
FEBS Open Bio; 2024 Feb; 14(2):290-299. PubMed ID: 38050660
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic Effects of FGF23 c-tail Fc in a Murine Preclinical Model of X-Linked Hypophosphatemia Via the Selective Modulation of Phosphate Reabsorption.
Johnson K; Levine K; Sergi J; Chamoun J; Roach R; Vekich J; Favis M; Horn M; Cao X; Miller B; Snyder W; Aivazian D; Reagan W; Berryman E; Colangelo J; Markiewicz V; Bagi CM; Brown TP; Coyle A; Mohammadi M; Magram J
J Bone Miner Res; 2017 Oct; 32(10):2062-2073. PubMed ID: 28600887
[TBL] [Abstract][Full Text] [Related]
37. FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF-23 signaling and regulating FGF-23 expression in bone.
Wöhrle S; Bonny O; Beluch N; Gaulis S; Stamm C; Scheibler M; Müller M; Kinzel B; Thuery A; Brueggen J; Hynes NE; Sellers WR; Hofmann F; Graus-Porta D
J Bone Miner Res; 2011 Oct; 26(10):2486-97. PubMed ID: 21812026
[TBL] [Abstract][Full Text] [Related]
38. The FGF23/KLOTHO Regulatory Network and Its Roles in Human Disorders.
Kinoshita S; Kawai M
Vitam Horm; 2016; 101():151-74. PubMed ID: 27125741
[TBL] [Abstract][Full Text] [Related]
39. Circulating levels of soluble klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status.
Carpenter TO; Insogna KL; Zhang JH; Ellis B; Nieman S; Simpson C; Olear E; Gundberg CM
J Clin Endocrinol Metab; 2010 Nov; 95(11):E352-7. PubMed ID: 20685863
[TBL] [Abstract][Full Text] [Related]
40. Vitamin D metabolism in pregnant rabbits: differences between the maternal and fetal response to administration of large amounts of vitamin D3.
Kubota M; Ohno J; Shiina Y; Suda T
Endocrinology; 1982 Jun; 110(6):1950-6. PubMed ID: 6280980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]